Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Share-based Compensation (2016 - 2017)

Historic Share-based Compensation for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to $64.0.

  • Tenax Therapeutics' Share-based Compensation fell 6862.75% to $64.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $79589.0, marking a year-over-year increase of 739425.61%. This contributed to the annual value of $1.1 million for FY2024, which is 48900.52% up from last year.
  • Latest data reveals that Tenax Therapeutics reported Share-based Compensation of $64.0 as of Q4 2017, which was down 6862.75% from $67.0 recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Share-based Compensation ranged from a high of $1.4 million in Q1 2014 and a low of $64.0 during Q4 2017
  • For the 5-year period, Tenax Therapeutics' Share-based Compensation averaged around $320446.5, with its median value being $14840.0 (2014).
  • As far as peak fluctuations go, Tenax Therapeutics' Share-based Compensation crashed by 9823.27% in 2015, and later soared by 2528594.25% in 2017.
  • Quarter analysis of 5 years shows Tenax Therapeutics' Share-based Compensation stood at $1.3 million in 2013, then plummeted by 97.24% to $34868.0 in 2014, then crashed by 99.23% to $268.0 in 2015, then decreased by 23.88% to $204.0 in 2016, then plummeted by 68.63% to $64.0 in 2017.
  • Its Share-based Compensation stands at $64.0 for Q4 2017, versus $67.0 for Q2 2017 and $79458.0 for Q1 2017.